PR Newswire#pr
BrainStorm Cell Therapeutics Announces Second Quarter 2026 Financial Results and Provides Corporate Updatetranslating…
1h agoFactuality: 70/100USACision
NEW YORK, Aug. 14, 2026 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (OTCQB: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced financial results for the second quarter ended June 30, 2026, and provided a corporate…